US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 4.160
  • 0.0000.00%
Close Apr 26 16:00 ET
  • 4.160
  • 0.0000.00%
Post 18:37 ET
858.34MMarket Cap-3525P/E (TTM)

BioCryst Pharmaceuticals Key Stats

BioCryst Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 6, 2024

Revenue(YoY)

85.51M

+24.32%
EPS(YoY)

-0.21

+24.76%

Strong Buy

Apr 22, 2024

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 98.283M--
May 6, 20242024/Q1-- / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--
Nov 2, 20232023/Q386.742M / 86.058M--
Aug 3, 20232023/Q282.491M / 81.430M--
May 3, 20232023/Q168.778M / 71.437M--
Feb 21, 20232022/Q479.545M / 74.179M--
Nov 1, 20222022/Q375.827M / 74.784M--
Aug 4, 20222022/Q265.532M / 63.826M--
May 5, 20222022/Q149.923M / 51.360M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 98.283M--
May 6, 20242024/Q1-- / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--
Nov 2, 20232023/Q386.742M / 86.058M--
Aug 3, 20232023/Q282.491M / 81.430M--
May 3, 20232023/Q168.778M / 71.437M--
Feb 21, 20232022/Q479.545M / 74.179M--
Nov 1, 20222022/Q375.827M / 74.784M--
Aug 4, 20222022/Q265.532M / 63.826M--
May 5, 20222022/Q149.923M / 51.360M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 22, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg